增强自噬作为开发新型日本脑炎DNA疫苗候选策略
本研究将日本脑炎病毒prM和E蛋白与LC3基因融合构建自噬介导的pJME-LC3 DNA疫苗,在转染细胞中观察到自噬体或LC3Ⅱ表达显著增加且融合蛋白定位于自噬体。免疫小鼠后CD3+CD8+ T淋巴细胞、CD8+效应记忆T细胞和JEV特异性CTL活性比例最高,血清IgG2a及脾细胞产生的IFN-γ、IL-12增强,偏向Th1型免疫应答。攻毒后小鼠存活率最高且产生持久中和抗体,伴随CD4+中央记忆T细胞比例增加。
要点
- 自噬介导的pJME-LC3 DNA疫苗可增强JEV特异性CTL活性与Th1型免疫应答。
- pJME-LC3免疫小鼠攻毒后存活率最高并产生持久中和抗体。
- 自噬可作为增强JEV疫苗免疫原性与长期免疫记忆的优化策略。
核心结论
- 自噬可作为优化策略增强JEV特异性免疫应答和长期免疫记忆。
研究设计与样本
- 构建自噬介导的pJME-LC3 DNA疫苗,将JEV prM和E蛋白与LC3编码基因融合。
- 在转染细胞中检测自噬体或LC3Ⅱ表达及融合蛋白与GFP-LC3共定位。
- 免疫小鼠后检测T淋巴细胞亚群、CTL活性、抗体和细胞因子,并进行JEV攻毒保护试验。
主要发现
- pJME-LC3转染细胞中自噬体或LC3Ⅱ表达显著增加,prME-LC3融合蛋白与GFP-LC3共定位于自噬体。
- 免疫小鼠后CD3+CD8+ T淋巴细胞、CD8+效应记忆T细胞和JEV特异性CTL活性比例最高。
- pJME-LC3增强血清IgG2a抗体及脾细胞产生的IFN-γ、IL-12,通过激活JAK2/STAT1信号通路上调T-bet表达偏向Th1型免疫应答。
- 攻毒后pJME-LC3免疫小鼠存活率最高且产生持久中和抗体,伴随CD4+中央记忆T细胞百分比增加。
临床怎么用
- 自噬增强策略可作为DNA疫苗设计方向,用于提升JEV疫苗的免疫原性和长期保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For decades, an on-going concerted effort has been made to develop a universal DNA vaccine to combat the looming threat of a potential outbreak of the emerging Japanese encephalitis virus (JEV) infection. However, effective strategies are urgently required to counter poor immunogenicity and insufficient long-term protection. Recent reports have confirmed the critical role of autophagy in antigen presentation, long-term immune memory and immune responses against JEV. In this study, JEV prM and E protein with strong immunogenicity were fused with microtubule-associated protein 1 light chain 3 (LC3) encoding gene to construct an autophagy-mediated pJME-LC3 DNA vaccine. Researches indicated significant increase of autophagosomes or LC3 Ⅱ expression in pJME-LC3 transfected cells. Furthermore, prME-LC3 fused protein was observed co-localized with GFP-LC3 to autophagosomes, which means it was successfully targeted to autophagosomes. After immunizing with pJME-LC3, mice were detected highest proportion of CD3+CD8+ T lymphocytes, CD8+ effector memory T cells (TEMs) and JEV specific cytotoxic T lymphocyte (CTL) activity to eliminate JEV. pJME-LC3 also enhanced IgG2a antibody in serum and cytokines IFN-γ, IL-12 produced by splenocytes, thus skew toward Th1 type immune response by activating the JAK2/STAT1 signaling pathway and upregulating expression of transcription factor T-bet. Notably, mice immunized with pJME-LC3 showed highest survival rate and long-lasting neutralizing antibody when challenged with virulent JEV, which were consistent with augment in percentage of CD4+ central memory T cells (TCMs). In brief, our studies suggested that autophagy can be used as a optimization strategy to enhance JEV specific immune response and long-term immune memory. Our attempt will contribute towards future efforts to develop an efficacious JEV vaccine.
引用
- Zhao F, Zhai Y, Zhu J, et al. Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis. Vaccine. 2019. PMID: 31399273. doi:10.1016/j.vaccine.2019.07.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。